A detailed history of Tekla Capital Management LLC transactions in I Mab stock. As of the latest transaction made, Tekla Capital Management LLC holds 162,580 shares of IMAB stock, worth $157,702. This represents 0.02% of its overall portfolio holdings.

Number of Shares
162,580
Previous 162,580 -0.0%
Holding current value
$157,702
Previous $562,000 13.52%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$47.86 - $83.95 $206,563 - $362,328
-4,316 Reduced 2.59%
162,580 $13.6 Million
Q1 2021

May 14, 2021

BUY
$44.38 - $63.97 $7.41 Million - $10.7 Million
166,896 New
166,896 $8.09 Million

Others Institutions Holding IMAB

About I-Mab


  • Ticker IMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,098,800
  • Market Cap $80.6M
  • Description
  • I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...
More about IMAB
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.